{"name":"ValiSeek Limited","slug":"valiseek-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQNzVQMnBDUlFEY3ROc09zQU12OEVUYkNlMjRLSXZwUmpldEhvZmo4VmwtS3B2N3lOek5KSXFHenpPS2ZUc3pVbWdxNzdXWm5lSzR5NExrb3pYc3FzbXIzTjBLTGFaU0hqTnFkenVtOHJvTzgtLVh0RjdCaGlkdGkwVS1KZGxCdw?oc=5","date":"2025-06-20","type":"pipeline","source":"Share Talk","summary":"ValiRx Plc (AIM: VAL): Ambrose Extends Option on VAL401 - Share Talk","headline":"ValiRx Plc (AIM: VAL): Ambrose Extends Option on VAL401","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9jTkNmTGk1R0htbmFwc0k2SmVycEdmZmRXdlowTzFqbUZsUG5EbzE5eHpJdjNmVHBBTnpMWFNvM2IyaTUtT0lyX1pfTGxjblpmeEhabGxqWnQyLXE4TXh3?oc=5","date":"2020-09-01","type":"pipeline","source":"nature.com","summary":"Reformulating a novel therapeutic for lung cancer - nature.com","headline":"Reformulating a novel therapeutic for lung cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}